Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, March 30, 2013
Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa
In continuation of my update on
dexamethasone
Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients.
Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment